A new method for imaging-guided synergistic cancer therapy

NewsGuard 100/100 Score

A joint research team led by Prof. WANG Hui and Prof. LIN Wenchu from the High Magnetic Field Laboratory of the Hefei Institutes of Physical Science developed a synthesis of metal-free multifunctional therapeutic reagents, called graphitic carbon nitride quantum dots embedded in carbon nanosheets (CNQD-CN), via a one-step hydrothermal treatment.

Metal-free multifunctional nanomaterials have broad application prospects in integrated cancer diagnosis and treatment.

The team took an organic solvent (formamide) as the carbon and nitrogen source and then developed CNQD-CN.

CNQD-CN can be utilized as a near-infrared (NIR)/pH dual-responsive drug delivery system to improve the response to chemotherapy. It possesses both light-to-heat conversion and singlet oxygen generation capabilities under a single NIR excitation wavelength for combined photodynamic and photothermal therapy.

The combination of graphitic carbon nitride quantum dots and two-dimensional carbon-based nanomaterials might be a potential candidate for realizing imaging-guided synergistic cancer therapy due to its excellent performance, including optical properties, efficient light-to-heat conversion capability, and near-infrared (NIR)-induced singlet oxygen generation."

Wang Hui, High Magnetic Field Laboratory, Hefei Institutes of Physical Science, Chinese Academy of Sciences, who designed the project

However, synthesis of related nanocomposites, including multiple reaction precursors, complex synthesis processes, potential weak interaction, produced large amounts of waste, thus limiting their scalable production and reproducibility.

This study was a further step in realizing the advantages of imaging-guided synergistic cancer therapy.

Source:
Journal reference:

Liu, H., et al. (2020) Graphitic Carbon Nitride Quantum Dots Embedded in Carbon Nanosheets for Near-Infrared Imaging-Guided Combined Photo-Chemotherapy. ACS Nano. doi.org/10.1021/acsnano.0c05143.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New trials show promise for immune checkpoint blockers in early-stage lung cancer